Christina Egebjerg

How hypocretin agonists may improve the quality of wake in narcolepsy.

B. Kornum, J. Justinussen, Christina Egebjerg, 2022, Trends in molecular medicine.

Ease‐of‐use and acceptability of the novel semaglutide 2.4 mg single‐dose pen‐injector in people with overweight or obesity in the STEP 8 phase III trial

S. Snitker, T. Sparre, M. Frederiksen, 2022, Diabetes, obesity & metabolism.

Molecular consequences of peripheral Influenza A infection on cell populations in the murine hypothalamus

T. Pers, J. Christensen, A. Thomsen, 2023, bioRxiv.